Impacto da pandemia da COVID-19 sobre o tratamento medicamentoso dos pacientes com doença arterial periférica: um estudo observacional transversal

Braghieri, Heloisa Amaral, Correia, Marília de Almeida, Carvalho, Juliana Ferreira de, Longano, Paulo, Wolosker, Nelson, Cucato, Gabriel, Ritti-Dias, Raphael Mendes and Kanegusuku, Hélcio (2021) Impacto da pandemia da COVID-19 sobre o tratamento medicamentoso dos pacientes com doença arterial periférica: um estudo observacional transversal. Jornal Vascular Brasileiro, 20. e20210021. ISSN 1677-5449

[img]
Preview
Text (Portuguese version)
Version of Record.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (400kB) | Preview
[img]
Preview
Text (English version)
Version of Record.pdf - Published Version
Available under License Creative Commons Attribution 4.0.

Download (389kB) | Preview
Official URL: https://doi.org/10.1590/1677-5449.210021

Abstract

Contexto: A pandemia do Coronavírus 2019 (COVID-19) tem afetado negativamente o comportamento dapopulação. Nesse contexto, o impacto da pandemia da COVID-19 no tratamento medicamentoso dos pacientes comdoença arterial periférica (DAP) e claudicação intermitente (CI) permanece obscuro. Objetivos: Analisar o impactoda pandemia da COVID-19 no tratamento medicamentoso dos pacientes com DAP e CI. Métodos: Neste estudoobservacional transversal, 136 pacientes com DAP e CI, recrutados do nosso banco de dados, responderam por telefoneum questionário envolvendo as seguintes questões: a) cuidados com a COVID-19; b) saúde global; c) tratamento dasdoenças. Posteriormente, os pacientes foram divididos em dois grupos, de acordo com a dificuldade para a aquisiçãodos medicamentos (DAM: dificuldade e SDAM: sem dificuldade), para a comparação da saúde global entre os doisgrupos. Resultados: Dezessete porcento dos pacientes reportaram dificuldades para a aquisição dos medicamentosdurante a pandemia. Uma maior prevalência desses pacientes reportou estar mais triste (56,5% versus 24,8%, p < 0,01)e com mais dificuldades para dormir (56,5% versus 24,8%, p < 0,01) em relação aos pacientes do grupo SDAM. Osgrupos não apresentaram diferenças para o declínio na capacidade de caminhada, ansiedade, estresse e depressão(p > 0,05). Conclusões: Uma maior prevalência de pacientes do grupo DAM reportou estar mais triste e com maisdificuldade para dormir em comparação ao grupo SDAM durante a pandemia da COVID-19. = Background: The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population’s behavior. In
this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD)
and intermittent claudication (IC) remains unclear. Objectives: To analyze the impact of the COVID-19 pandemic on
drug treatment of patients with PAD and IC. Methods: In this cross-sectional, observational study, 136 patients with
PAD and IC were recruited from our database and answered a questionnaire by telephone involving the following
questions: a) precautions related to COVID-19; b) general health status; and c) treatment of diseases. Subsequently,
patients were divided into two groups according to difficulty in obtaining their drugs (DOD: difficulty obtaining drugs,
or NDOD: no difficulty obtaining drugs) and overall health was compared between groups. Results: Seventeen percent
of patients reported difficulties with obtaining drugs during the pandemic. A higher proportion of these patients
reported being sadder (56.5% vs. 24.8%, P < 0.01) and having more difficulty sleeping (56.5% vs. 24.8%, P < 0.01) than
of the patients in the NDOD group (P <0.01). The groups did not differ in terms of impairment of walking capability,
anxiety, stress, or depression (P> 0.05). Conclusions: A higher proportion of patients in the DOD group reported
being sadder and having greater difficulty sleeping compared to the NDOD group during the COVID-19 pandemic.

Item Type: Article
Uncontrolled Keywords: COVID-19, isolamento socia, claudicação intermitente, tratamento medicamentoso, saúde, SARS-CoV-2. = COVID-19, social isolation, intermittent claudication, drug treatment, health, SARS-CoV-2.
Subjects: B100 Anatomy, Physiology and Pathology
C600 Sports Science
Department: Faculties > Health and Life Sciences > Sport, Exercise and Rehabilitation
Depositing User: Rachel Branson
Date Deposited: 09 Jul 2021 09:31
Last Modified: 04 Aug 2021 16:30
URI: http://nrl.northumbria.ac.uk/id/eprint/46642

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics